Clinical Trial Update: Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TollB-001 tablets for safety and efficacy in moderate to severe rheumatoid arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• TollB-001

Snippet

Sponsor: Toll Biotech Co. Ltd. (Beijing) | Conditions: Rheumatoid Arthritis (RA) | Phase 2 | Status: RECRUITING